AbbVie (ABBV) EV to EBITDA (2013 - 2026)
AbbVie's (ABBV) EV to EBITDA stood at 15.61 in Q3 2026, down 32.7% from 23.19 a year earlier and down 11.7% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) EV to EBITDA (2013 - 2026) Analysis & Trends
On a TTM basis, AbbVie's EV to EBITDA came in at 14.88 as of Sep 30, 2026, down 33.0% year-over-year; for FY2025, it came in at 17.16, down 2.4% from FY2024.
- Across earlier years, EV to EBITDA came in at 17.59 in FY2024 (+44.6%), 12.16 in FY2023 (+16.9%), 10.41 in FY2022 (+19.8%) and 8.69 in FY2021 (-14.3%).
- The Q3 2026 figure is the lowest quarterly EV to EBITDA since Q3 2024.
- On a year-over-year basis, EV to EBITDA rose in five of the last eight quarters, with growth averaging 13.0%.
- Peak year-over-year performance for EV to EBITDA in the last five years was growth of 60.1% in Q2 2024, against a decline of 32.7% in Q3 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at 17.67 (Q2 2026), 15.99 (Q1 2026) and 17.09 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 15.61 |
| Jun 30, 2026 | 17.67 |
| Mar 31, 2026 | 15.99 |
| Dec 31, 2025 | 17.09 |
| Sep 30, 2025 | 23.19 |
| Jun 30, 2025 | 16.63 |
| Mar 31, 2025 | 19.80 |
| Dec 31, 2024 | 17.61 |
| Sep 30, 2024 | 15.45 |
| Jun 30, 2024 | 14.02 |
| Mar 31, 2024 | 14.19 |
| Dec 31, 2023 | 12.19 |
| Sep 30, 2023 | 10.48 |
| Jun 30, 2023 | 8.76 |
| Mar 31, 2023 | 11.14 |
| Dec 31, 2022 | 10.42 |
| Sep 30, 2022 | 8.69 |
| Jun 30, 2022 | 10.19 |
| Mar 31, 2022 | 10.35 |
| Dec 31, 2021 | 8.69 |
API Access
AbbVie EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();